Metabolites · Nov 16, 2026

Evidence for a Conserved Metabolic Architecture of Cellular Senescence Across Neurodegenerative Diseases: A Systematic Review

By Slocum DL, Duka D, Antonelli L et al.

Background: Cellular senescence contributes to neurodegenerative disease through chronic inflammatory signaling, mitochondrial dysfunction, and metabolic remodeling. Although metabolomic studies have identified numerous metabolic abnormalities in neurodegeneration, their relationship with cellular senescence has not been systematically evaluated. Methods: This systematic review followed PRISMA 2020 guidelines. An artificial intelligence-assisted semantic search using Elicit was supplemented by investigator-led screening and additional PubMed and Embase searches. Twenty-three peer-reviewed studies met predefined eligibility criteria. Data were verified against the original publications and synthesized qualitatively according to recurring metabolic pathways and senescence-associated mechanisms. Results: Four recurrent metabolic themes emerged: (1) disruption of NAD+ homeostasis, purine/nucleotide, and redox metabolism; (2) mitochondrial dysfunction and glycolytic reprogramming; (3) lipid remodeling, including cholesterol, oxysterol, sphingolipid, and lipid-droplet dysregulation; and (4) circulating metabolic signatures with potential translational relevance. These alterations repeatedly converged on senescence-associated features including oxidative stress, mitochondrial dysfunction, chronic inflammatory signaling, and activation of p16INK4a-, p21Cip1-, and SASP-related pathways. In preclinical models, interventions targeting NAD+ metabolism, mitochondrial function, lipid homeostasis, autophagy, or senescent cells attenuated senescence-associated phenotypes and improved metabolic homeostasis. Conclusions: Current evidence supports a close association between metabolic remodeling and cellular senescence in neurodegenerative disease. Rather than a single senescence-specific metabolite, coordinated alterations across interconnected metabolic networks appear to provide more informative indicators of the senescent phenotype. Integrated multi-omic approaches may therefore improve biomarker development and identify metabolism-based therapeutic strategies, although methodological heterogeneity and limited longitudinal human data remain important barriers to clinical translation.

doi.org/10.3390/metabo16110896Open accessMechanisms

AgingResearch.News